Navigation Links
Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)
Date:8/23/2011

NEW YORK, Aug. 23, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)

http://www.reportlinker.com/p0595074/Biochips-Market-DNA-Microarrays-Lab-on-Chip-Protein-Microarrays-Tissue--Cell-Arrays-Trends--Global-Forecast-2010-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

Report Description

A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on a solid platform that allows multiple tests to be performed at the same time with increased efficiency and higher speed. The global biochip market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 billion by 2015; growing at a CAGR of 16.7%. This growth is attributed to increasing applications in cancer diagnostics and expression profiling, the boom in personalized medicine, and government funding.

DNA microarrays represent the largest segment of this market and will continue to be the largest contributor during the study period (2010-2015). However, this segment will be closely followed by lab-on-chip (LOC) in the coming years due to its wide applications and increased adoption by various biotechnology, pharmaceutical companies, and research laboratories. The third largest segment – protein microarrays will be the fastest growing segment; forecasted to grow at a CAGR of 19.9% during the study period due to advances in the fields of genomics and proteomics and improvements in the field of recombinant proteins.

Reverse phase protein microarrays designed for targeted therapies in cancer holds promise in the global biochip market in the next 5-10 years. These microarrays provide increased accuracy and enhanced efficacy for the detection of rare molecules as compared to existing microarray surfaces for cancer research & diagnosis to help understand the proteins in tumor cells. Thus, they have helped open the avenues for personalized methods for cancer therapy.

The market of Asia will account for a bulk of the future biochip market growth due to its high growth potential and huge demand from emerging economies such as India and China - the large pool of heterogeneous patient population, and increasing R&D investment in these countries. The top players in the biochip market such as Affymetrix, Inc., Illumina, Inc., and Fluidigm Corporation have relocated their manufacturing base to Singapore to take advantage of the benefits the country offers; coupled with rising demand from neighboring countries of Asia. The players also benefit from a well-established semiconductor manufacturing base including chip technologies. Singapore has made focused efforts to attract life sciences corporates with dedicated investments accounting for 3% of the country's GDP. It came up with its R&D center - Singapore's Biopolis R&D center in 2003-2004 and is home to the Genome Institute of Singapore.

Scope of the report

This research report categorizes the global biochips market on the basis of applications, types, and geography; forecasting revenues and analyzing trends in each of the following submarkets:

On the basis of applications:

DNA applications: Gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, agricultural biotechnology, drug discovery, and others.

Lab on chip applications: Drug discovery, genomics, diagnostics, proteomics, IVD & POC, high throughput screening, and others.

Protein microarray applications: Expression profiling, proteomics, high throughput screening, diagnostics, drug discovery, and others.

Other array applications: Expression profiling, cancer diagnostics, toxicogenomics, genomics, drug discovery, and others.

On the basis of types:

DNA microarrays, lab on chip, protein microarrays, other arrays (cell arrays and tissue arrays)

On the basis of geography:

North America, Europe, Asia, and Rest of the World.

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. It will also provide market tables for covering the sub-segments. In addition, the report will throw light on more than 20 company profiles covering all the sub-segments.

TABLE OF CONTENTS

1 INTRODUCTION

1.1 KEY TAKE-AWAYS

1.2 REPORT DESCRIPTION

1.3 MARKETS COVERED

1.4 STAKEHOLDERS

1.5 RESEARCH METHODOLOGY

1.5.1 MARKET SIZE

1.5.2 KEY DATA POINTS FROM SECONDARY SOURCES

1.5.3 KEY DATA POINTS FROM PRIMARY SOURCES

1.5.4 MARKET SHARE

1.5.5 ASSUMPTIONS MADE FOR THE REPORT

2 EXECUTIVE SUMMARY

2.1 OVERVIEW OF THE MARKET

2.2 KEY FINDINGS

2.3 RECOMMENDATIONS

2.3.1 APPLICATION OF REVERSE PHASE PROTEIN MICROARRAYS IN CANCER DIAGNOSIS IS A LUCRATIVE INVESTMENT OPTION

3 MARKET OVERVIEW

3.1 INTRODUCTION

3.2 BURNING ISSUE

3.2.1 EMERGENCE OF NEW DISEASES & DISEASE COMPLEXITY CATALYZE ADOPTION OF BIOCHIPS IN DIAGNOSTICS

3.3 WINNING IMPERATIVES

3.3.1 STANDARDIZATION IS A NECESSITY

3.3.2 COST

3.3.3 NEED OF CROSS COMPATIBILITY

3.3.4 END-TO-END SOLUTIONS

3.4 MARKET DYNAMICS

3.4.1 DRIVERS

3.4.1.1 Growth in personalized medicine

3.4.1.2 Increase Government funding

3.4.1.3 Cancer diagnosis & treatment is on a rise

3.4.1.4 Technical advances

3.4.2 RESTRAINTS

3.4.2.1 Knowledge constraints with respect to technical know-how

3.4.2.2 Lack of healthcare coverage restricts the adoption

3.4.3 OPPORTUNITIES

3.4.3.1 Growth of market in the sub-continent of Asia

3.4.3.2 Widening applications market

3.4.4 TRENDS

3.4.4.1 Robust deals & alliances

3.4.4.2 Relocating manufacturing facilities to gain competitive edge

3.4.4.2.1 Advantage Singapore

3.4.4.3 Next generation technology for LOC

3.4.4.3.1 Lab on CD-ROM

3.4.4.3.2 EFAD chip technology

3.4.4.4 Outsourcing of the biochip technology

3.4.4.4.1 Reduction in the labor cost

3.4.4.4.2 Increased focus on core business

3.4.4.4.3 Risk reduction

3.4.4.4.4 Utilization of business expertise

3.4.4.4.5 Reduction in capital expenditure

3.5 MARKET BREAKDOWN

3.6 END-USER ANALYSIS

3.7 MARKET SHARE ANALYSIS

3.7.1 DNA MICROARRAY MARKET SHARE ANALYSIS

3.7.2 LOC/MICROFLUIDICS MARKET SHARE ANALYSIS

3.7.3 PROTEIN MICROARRAY MARKET SHARE ANALYSIS

4 GLOBAL DNA MICROARRAY MARKET

4.1 INTRODUCTION

4.2 DNA MICROARRAY MARKET, BY APPLICATIONS

4.2.1 GENE EXPRESSION

4.2.2 SNP GENOTYPING

4.2.3 CANCER DIAGNOSIS & TREATMENT

4.2.4 GENOMICS

4.2.5 AGRICULTURAL BIOTECHNOLOGY

4.2.6 DRUG DISCOVERY

4.2.7 OTHERS

5 GLOBAL LAB-ON-CHIP/MICROFLUIDICS MARKET

5.1 INTRODUCTION

5.2 LOC/MICROFLUIDICS MARKET, BY APPLICATIONS

5.2.1 HIGH THROUGHPUT SCREENING

5.2.2 GENOMICS

5.2.3 PROTEOMICS

5.2.4 DRUG DISCOVERY

5.2.5 IVD & POC

5.2.6 DIAGNOSTICS

5.2.7 OTHERS

6 GLOBAL PROTEIN MICROARRAY MARKET

6.1 INTRODUCTION

6.2 PROTEIN MICROARRAY MARKET, BY TYPES

6.2.1 EXPRESSIONAL PROTEIN MICROARRAY

6.2.2 FUNCTIONAL PROTEIN MICROARRAY

6.2.3 REVERSE PHASE PROTEIN MICROARRAY

6.3 PROTEIN MICROARRAY MARKET, BY APPLICATIONS

6.3.1 EXPRESSION PROFILING

6.3.2 PROTEOMICS

6.3.3 HIGH THROUGHPUT SCREENING

6.3.4 DIAGNOSTICS

6.3.5 DRUG DISCOVERY

6.3.6 OTHERS

7 GLOBAL OTHER ARRAYS MARKET

7.1 OTHER ARRAYS MARKET, BY TYPES

7.1.1 CELL ARRAY

7.1.2 TISSUE ARRAY

7.1.2.1 FFPE Arrays

7.1.2.2 Frozen Arrays

7.2 OTHER ARRAYS MARKET, BY APPLICATIONS

7.2.1 EXPRESSION PROFILING

7.2.2 CANCER DIAGNOSTICS

7.2.3 TOXICOGENOMICS

7.2.4 GENOMICS

7.2.5 DRUG DISCOVERY

7.2.6 OTHERS

8 GLOBAL BIOCHIP MARKET, BY GEOGRAPHY

8.1 INTRODUCTION

8.2 NORTH AMERICA

8.3 EUROPE

8.4 ASIA

8.5 ROW

9 COMPETITIVE LANDSCAPE

9.1 KEY STRATEGIES

10 COMPANY PROFILES

10.1 AFFYMETRIX INC

10.1.1 OVERVIEW

10.1.2 FINANCIALS

10.1.3 PRODUCTS & SERVICES

10.1.4 STRATEGY

10.1.5 DEVELOPMENTS

10.2 AGILENT TECHNOLOGIES INC

10.2.1 OVERVIEW

10.2.2 FINANCIALS

10.2.3 PRODUCTS & SERVICES

10.2.4 STRATEGY

10.2.5 DEVELOPMENTS

10.3 BIOCHAIN INSTITUTE INC

10.3.1 OVERVIEW

10.3.2 FINANCIALS

10.3.3 PRODUCTS & SERVICES

10.3.4 STRATEGY

10.3.5 DEVELOPMENTS

10.4 BIOMÉRIEUX SA

10.4.1 OVERVIEW

10.4.2 FINANCIALS

10.4.3 PRODUCTS & SERVICES

10.4.4 STRATEGY

10.4.5 DEVELOPMENTS

10.5 BIO-RAD LABORATORIES INC

10.5.1 OVERVIEW

10.5.2 FINANCIALS

10.5.3 PRODUCTS & SERVICES

10.5.4 STRATEGY

10.5.5 DEVELOPMENTS

10.6 CALIPER LIFE SCIENCES INC

10.6.1 OVERVIEW

10.6.2 FINANCIALS

10.6.3 PRODUCTS & SERVICES

10.6.4 STRATEGY

10.6.5 DEVELOPMENTS

10.7 CEPHEID INC

10.7.1 OVERVIEW

10.7.2 FINANCIALS

10.7.3 PRODUCTS & SERVICES

10.7.4 STRATEGY

10.7.5 DEVELOPMENTS

10.8 CYBRDI INC

10.8.1 OVERVIEW

10.8.2 FINANCIALS

10.8.3 PRODUCTS & SERVICES

10.8.4 STRATEGY

10.8.5 DEVELOPMENTS

10.9 EMD MILLIPORE

10.9.1 OVERVIEW

10.9.2 FINANCIALS

10.9.3 PRODUCTS & SERVICES

10.9.4 STRATEGY

10.9.5 DEVELOPMENTS

10.10 FLUIDIGM CORP

10.10.1 OVERVIEW

10.10.2 FINANCIALS

10.10.3 PRODUCTS & SERVICES

10.10.4 STRATEGY

10.10.5 DEVELOPMENTS

10.11 GAMIDA FOR LIFE GROUP

10.11.1 OVERVIEW

10.11.2 FINANCIALS

10.11.3 PRODUCTS & SERVICES

10.11.4 STRATEGY

10.11.5 DEVELOPMENTS

10.12 ILLUMINA INC

10.12.1 OVERVIEW

10.12.2 FINANCIALS

10.12.3 PRODUCTS & SERVICES

10.12.4 STRATEGY

10.12.5 DEVELOPMENTS

10.13 LIFE TECHNOLOGIES CORP

10.13.1 OVERVIEW

10.13.2 FINANCIALS

10.13.3 PRODUCTS & SERVICES

10.13.4 STRATEGY

10.13.5 DEVELOPMENTS

10.14 ORIGENE TECHNOLOGIES INC

10.14.1 OVERVIEW

10.14.2 FINANCIALS

10.14.3 PRODUCTS & SERVICES

10.14.4 STRATEGY

10.14.5 DEVELOPMENTS

10.15 PERKINELMER INC

10.15.1 OVERVIEW

10.15.2 FINANCIALS

10.15.3 PRODUCTS & SERVICES

10.15.4 STRATEGY

10.15.5 DEVELOPMENTS

10.16 ROCHE NIMBLEGEN INC

10.16.1 OVERVIEW

10.16.2 FINANCIALS

10.16.3 PRODUCTS & SERVICES

10.16.4 STRATEGY

10.16.5 DEVELOPMENTS

10.17 SEQUENOM

10.17.1 OVERVIEW

10.17.2 FINANCIALS

10.17.3 PRODUCTS & SERVICES

10.17.4 STRATEGY

10.17.5 DEVELOPMENTS

10.18 SIGMA ALDRICH CORP

10.18.1 OVERVIEW

10.18.2 FINANCIALS

10.18.3 PRODUCTS & SERVICES

10.18.4 STRATEGY

10.18.5 DEVELOPMENTS

10.19 OTHERS

10.19.1 IMGENEX

10.19.1.1 Overview

10.19.1.2 Financials

10.19.1.3 Products & services

10.19.2 ISU ABXIS CO. LTD

10.19.2.1 Overview

10.19.2.2 Financials

10.19.2.3 Products & services

10.19.3 US BIOMAX INC

10.19.3.1 Overview

10.19.3.2 Financials

10.19.3.3 Products & services

LIST OF TABLES

TABLE 1 GLOBAL BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 – 2015 ($MILLION)

TABLE 2 LIFE EXPECTANCY AT BIRTH

TABLE 3 TAX ENVIRONMENT

TABLE 4 TAX ENVIRONMENT: FOR NEW START UP COMPANIES IN SINGAPORE

TABLE 5 DNA MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 6 TOP FIVE DNA MICROARRAY TECHNOLOGIES

TABLE 7 COMPARISON BETWEEN PHOTOLITHOGRAPHY & INKJET TECHNOLOGY

TABLE 8 GLOBAL DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 9 DNA MICROARRAY: GENE EXPRESSION MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 10 DNA MICROARRAY: SNP GENOTYPING MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 11 DNA MICROARRAY: CANCER DIAGNOSIS & TREATMENT MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 12 DNA MICROARRAY: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 13 DNA MICROARRAY: AGRICULTURAL BIOTECHNOLOGY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 14 DNA MICROARRAY: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 15 DNA MICROARRAY: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 16 LOC MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 17 GLOBAL LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 18 COMPARATIVE ANALYSIS OF MICROFLUIDIC ASSAY TECHNIQUES

TABLE 19 LOC: HTS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 20 LOC: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 21 LOC: PROTEOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 22 LOC: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 23 LOC: IVD & POC MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 24 LOC: DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 25 LOC: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 26 PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 27 PROTEIN MICROARRAY MANUFACTURING TECHNOLOGIES

TABLE 28 GLOBAL PROTEIN MICROARRAY MARKET REVENUE, BY TYPES, 2008 - 2015 ($MILLION)

TABLE 29 EXPRESSIONAL PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 30 FUNCTIONAL PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 31 REVERSE PHASE PROTEIN MICROARRAY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 32 GLOBAL PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 33 PROTEIN MICROARRAY APPLICATIONS IN EXPRESSION PROFILING

TABLE 34 PROTEIN MICROARRAY: EXPRESSION PROFILING MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 35 PROTEIN MICROARRAY APPLICATIONS IN PROTEOMICS

TABLE 36 PROTEIN MICROARRAY: PROTEOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 37 PROTEIN MICROARRAY: HTS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 38 PROTEIN MICROARRAY: DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 39 PROTEIN MICROARRAY: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 40 PROTEIN MICROARRAY: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 41 GLOBAL OTHER ARRAYS MARKET REVENUE, BY TYPES, 2008 - 2015 ($MILLION)

TABLE 42 OTHER ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 43 CELL ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 44 GLOBAL TISSUE ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 45 TISSUE ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 46 FFPE ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 47 FROZEN ARRAYS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 48 GLOBAL OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 49 OTHER ARRAYS: EXPRESSION PROFILING MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 50 OTHER ARRAYS: CANCER DIAGNOSTICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 51 OTHER ARRAYS: TOXICOGENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 52 OTHER ARRAYS: GENOMICS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 53 OTHER ARRAYS: DRUG DISCOVERY MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 54 OTHER ARRAYS: OTHERS MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 55 BIOCHIP MARKET REVENUE, BY GEOGRAPHY, 2008 - 2015 ($MILLION)

TABLE 56 NORTH AMERICA: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 57 NORTH AMERICA: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 58 NORTH AMERICA: PROTEIN MICROARRAY MARKET REVENUE,BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 59 NORTH AMERICA: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 60 NORTH AMERICA: LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 61 NORTH AMERICA: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 62 NORTH AMERICA: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 63 EUROPE: BIOCHIP MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 64 EUROPE: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 65 EUROPE: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 66 EUROPE: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 67 EUROPE: LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 68 EUROPE: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 69 EUROPE: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 70 ASIA: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 71 ASIA: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 72 ASIA: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 73 ASIA: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 74 ASIA: LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 75 ASIA: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 76 ASIA: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 77 ROW: BIOCHIP MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 78 ROW: DNA MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 79 ROW: PROTEIN MICROARRAY MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 80 ROW: PROTEIN MICROARRAY MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 81 ROW: LOC MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 82 ROW: OTHER ARRAYS MARKET REVENUE, BY PRODUCTS, 2008 - 2015 ($MILLION)

TABLE 83 ROW: OTHER ARRAYS MARKET REVENUE, BY APPLICATIONS, 2008 - 2015 ($MILLION)

TABLE 84 NEW PRODUCT LAUNCHES

TABLE 85 AGREEMENTS & COLLABORATIONS

TABLE 86 MERGERS & ACQUISITIONS

TABLE 87 AFFYMETRIX INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)

TABLE 88 AFFYMETRIX INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)

TABLE 89 AFFYMETRIX INC: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)

TABLE 90 AGILENT TECHNOLOGIES: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)

TABLE 91 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)

TABLE 92 AGILENT TECHNOLOGIES: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)

TABLE 93 BIOMÉRIEUX SA: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)

TABLE 94 BIO-RAD LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)

TABLE 95 BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)

TABLE 96 BIO-RAD LABORATORIES: MARKET REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)

TABLE 97 CALIPER LIFE SCIENCES INC: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($THOUSAND)

TABLE 98 CALIPER LIFE SCIENCES INC:TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($THOUSAND)

TABLE 99 CALIPER LIFE SCIENCES INC: TOTAL REVENUE, BY SEGMENTS, 2009 - 2010 ($THOUSAND)

TABLE 100 CEPHEID INC.: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($THOUSAND)

TABLE 101 CEPHEID: TOTAL PRODUCT REVENUE, BY GEOGRAPHY, 2008 - 2010 ($THOUSAND)

TABLE 102 CEPHEID: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($THOUSAND)

TABLE 103 CEPHEID: TOTAL REVENUE, BY SUB-SEGMENTS, 2008 - 2010 ($THOUSAND)

TABLE 104 CYBRDI INC: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2010 ($THOUSAND)

TABLE 105 CYBRDI INC: TOTAL REVENUE, BY COUNTRY, 2009 - 2010 ($THOUSAND)

TABLE 106 CYBRDI INC: TOTAL REVENUE, BY SEGMENTS ($THOUSAND)

TABLE 107 FLUIDIGM CORP: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($THOUSAND)

TABLE 108 FLUIDIGM CORP: TOTAL PRODUCTS REVENUE, BY GEOGRAPHY, 2008 - 2010 ($THOUSAND)

TABLE 109 FLUIDIGM CORP: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($THOUSAND)

TABLE 110 ILLUMINA INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($THOUSAND)

TABLE 111 ILLUMINA INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($THOUSAND)

TABLE 112 ILLUMINA INC: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($THOUSAND)

TABLE 113 LIFE TECHNOLOGIES CORP: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)

TABLE 114 LIFE TECHNOLOGIES CORP: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($THOUSAND)

TABLE 115 LIFE TECHNOLOGIES CORP: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)

TABLE 116 PERKINELMER INC: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)

TABLE 117 PERKINELMER INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)

TABLE 118 PERKINELMER INC: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)

TABLE 119 SEQUENOM INC: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($THOUSAND)

TABLE 120 SEQUENOM INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($THOUSAND)

TABLE 121 SEQUENOM INC: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($THOUSAND)

TABLE 122 SIGMA-ALDRICH: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)

TABLE 123 SIGMA-ALDRICH: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)

TABLE 124 SIGMA-ALDRICH: TOTAL REVENUE, BY SEGMENTS, 2008 - 2010 ($MILLION)

TABLE 125 ISU ABXIS CO. LTD: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($THOUSAND)

LIST OF FIGURES

FIGURE 1 BIOCHIP MARKET SEGMENTATION

FIGURE 2 GLOBAL BIOCHIP MARKET, 2010 VS 2015

FIGURE 3 MARKET COMPOSITION, 2010

FIGURE 4 COMPOSITION OF END-USERS, 2010

FIGURE 5 DNA MICROARRAY MARKET SHARE ANALYSIS, BY COMPANIES, 2010

FIGURE 6 GLOBAL LAB-ON-CHIP MARKET SHARE ANALYSIS, BY COMPANIES, 2010

FIGURE 7 GLOBAL PROTEIN MICROARRAY MARKET SHARE ANALYSIS, BY COMPANIES, 2010

FIGURE 8 DNA MICROARRAY MARKET - APPLICATIONS MARKET SEGMENTATION

FIGURE 9 LAB-ON-CHIP APPLICATIONS MARKET SEGMENTATION

FIGURE 10 APPLICATION OF LAB-ON-CHIP TECHNOLOGY IN DRUG DISCOVERY

FIGURE 11 PROTEIN MICROARRAY APPLICATIONS MARKET SEGMENTATION

FIGURE 12 KEY GROWTH STRATEGIES, JANUARY 2008 - JUNE 2011

To order this report:

Genomics Industry: Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)

Genomics Business News

More  Industry Analysis and Insights

__________________________

Contact Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Biochips: Genosensors, Microarrays, Labs-On-The-Chip
2. Reportlinker Adds Biochips and Microarrays - Technologies, markets and companies
3. Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips
4. Reportlinker Adds Global Biochips Industry
5. Reportlinker Adds Biochips - Products, Applications, Technologies and End-Use Markets Growth Analysis, 2009-2015
6. Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
7. Reportlinker Adds The 2011 Molecular Diagnostics Market: DNA Probes and Biochips New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
8. Reportlinker Adds Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
9. BioRestorative Therapies, Inc. Announces Upgrade to OTCQB Market
10. Tumor Marker Diagnostic Technologies: Assessment of Current and Emerging Technologies, And Their Potential Market Applications
11. Global Genetic Testing Market Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... LATHAM, NEW YORK... Marktech Optoelectronics will ... conference in San Francisco’s Moscone Center from February 16-18, 2016, and at the ... These latest InGaAs PIN diode standard packages feature a TO-46 metal can with active ...
(Date:2/10/2016)... MA (PRWEB) , ... February 10, 2016 , ... ... is now available on Microsoft Azure. On Azure, Arvados provides capabilities for managing ... saw clear demand for Microsoft Azure from major institutions collecting and analyzing genomic ...
(Date:2/10/2016)... Vancouver, BC (PRWEB) , ... February 09, 2016 ... ... and design services and current winner of the Highest Overall Customer Rating ... certification in all of its business units across the USA, Canada, Mexico and ...
(Date:2/9/2016)... ... February 08, 2016 , ... Date and time: March ... at the Pennsylvania Biotechnology Center of Bucks County, 3805 Old Easton Road, Doylestown, ... (TCMC) will hold an open house for participants to learn about a new ...
Breaking Biology Technology:
(Date:2/3/2016)... Feb. 3, 2016 Vigilant Solutions announces today ... in Missouri solved two recent ... (LPR) data from Vigilant Solutions. Brian Wenberg ... which the victim was walking out of a convenience store and witnessed an ... to his vehicle, striking his vehicle and leaving the ...
(Date:2/2/2016)... 2016 This BCC Research report provides ... reviewing the recent advances in high throughput ‘omic ... field forward. Includes forecast through 2019. ... and opportunities that exist in the bioinformatic market. ... as well as IT and bioinformatics service providers. ...
(Date:2/2/2016)... , Feb. 2, 2016   Parabon NanoLabs ... the U.S. Army Research Office and the Defense ... and sensitivity of the company,s Snapshot Kinship ... Mission and, more generally, defense-related DNA forensics.  Although ... capabilities (predicting appearance and ancestry from DNA evidence), ...
Breaking Biology News(10 mins):